甘爱萍治疗腹泻型肠易激综合征(肝郁脾虚证)的临床疗效观察

张萌; 朱光建

doi:10.3969/j.issn.1671-038X.2017.11.10

甘爱萍治疗腹泻型肠易激综合征(肝郁脾虚证)的临床疗效观察

张萌^1, ,,
朱光建²

- 1. 湖北省中医院, 湖北武汉 430061;
- 2. 湖北中医药大学中医临床学院, 湖北武汉 430061

详细信息

通讯作者: 张萌,E-mail:7866059@qq.com

中图分类号: R442.2

收稿日期: 2017-04-10

Clinical observation of Gan Aiping’s experiences in treatment of liver stagnation and spleen deficiency syndrome and diarrhea-predominant irritable bowel syndrome

ZHANG Meng^1, ,,
ZHU Guang-jian²

- 1. Hubei Hospital of Traditional Chinese Medicine, Wuhan 430061, China;
- 2. Hubei University of Traditional Chinese Medicine, Wuhan 430061, China

More Information

Corresponding author: ZHANG Meng, E-mail: 7866059@qq.com

Received Date: 10 April 2017

摘要

摘要: [目的]探讨甘爱萍教授用自拟方"肠泻宁"医治腹泻型肠易激综合征(肝郁脾虚证)患者的临床疗效,从中归纳可推广的宝贵经验。[方法]依照中西医诊断标准,归避影响因素,挑选出60例试验者,随机分成治疗组和对照组,每组30例,治疗组予以"肠泻宁"辨证化裁,对照组予以匹维溴铵片口服,疗程各为1个月。继而从综合疗效、中医证候积分、治疗后三个月的复发率、安全性4个方面评价2组疗效。[结果]经数据精准分析,相比于医治前,2组医治后的综合疗效、中医证候积分均有明显变化,差异有统计学意义(P＜0.05),医治后2组间对比,"肠泻宁"组较之"匹维溴铵"组疗效更为突出,差异有统计学意义(P＜0.05),2组治疗后3个月复发情况比较,"肠泻宁"组明显低于"匹维溴铵"组(P＜0.01)。[结论]"肠泻宁"功可疏肝健脾、渗湿止泻,方药组成精确合理,对于肠易激综合征治疗效果显著。
- 肠易激综合征 /
- 肝郁脾虚 /
- 腹泻 /
- 肠泻宁
Abstract: [Objective]To investigate the clinical efficacy of Gan Aiping’s experiential Changxiening decoction in treatment of liver stagnation and spleen deficiency syndrome of IBS-D,and sum up valued experiences.[Methods]According to the diagnostic criteria of Chinese and western medicine,60 patients were selected and divided into two 2 groups equally and randomly.The treatment group was given Changxiening decoction,and the control group was given pinaverium bromide tablets.The course of treatment was one month.Then to evaluate the efficacy based on comprehensive efficacy,score of TCM syndrome,recurrence rate of three months after treatment and safety.[Results]Two groups after treatment both had significant differences in comprehensive efficacy and score of TCM syndrome,and differences were statistical significance(P＜0.05).The comparison of two groups showed that treatment group had better efficacy than control group,and differences were statistical significance(P＜0.05).The treatment group had lower recurrence rate than the control group,and differences were statistical significance(P＜0.001).[Conclusion]Changxiening decoction,which is precisely formed of certain herbs,can smooth liver and strengthen spleen,and has prominent effect on IBS-D.
- irritable bowel syndrome /
- liver stagnation and spleen deficiency syndrome /
- diarrhea /
- Changxiening decoction

HTML全文

参考文献(16)

[1]	邓建春.中医治疗腹泻型肠易激综合征研究进展[J].北方药学, 2016, 13 (2):130-131.
[2]	葛均波, 徐永健主编.内科学[M].北京:人民卫生出版社, 2013:400-400.
[3]	郑筱萸.中药新药临床研究指导原则[S].北京:中国医药科技出版社, 2002:364-366.
[4]	赵鑫鑫, 王文龙, 钱海, 等.肠易激综合征治疗药物的研究进展[J].中国药科大学学报, 2011, 42 (2):182-188.
[5]	戴晓兰, 徐进康.肠易激综合征的中医研究进展[J].2014, 34 (6):940-942.
[6]	黎俊民.木槿花临证应用心得[J].辽宁中医药大学学报, 2006, 8 (6):127-127.
[7]	李伟, 郑天珍, 瞿颂义, 等.陈皮对大鼠胃平滑肌条收缩活动的作用及机制的探讨[J].中国中西医结合杂志, 2000, 20 (特集):49-49.
[8]	施文荣, 刘艳, 陈玲, 等.白术燥湿利水作用的研究[J].福建中医学院学报, 2007, 17 (3):29-31.
[9]	李文, 李丽, 是元艳, 等.防风有效部位的药理作用研究[J].中国实验方剂学杂志, 2006, 12 (6):29-31.
[10]	张利.白芍的药理作用及现代研究进展[J].中医临床研究, 2014, 6 (29):25-26.
[11]	张钟媛.茯苓药理作用研究进展[J]继续医学教育, 2015, 29 (5):108-109.
[12]	於怀龙, 怀晴晴, 薛玲.中药芡实预防急性胃粘膜损伤药理作用的研究[J].药学研究, 2013, 32 (6):326-329.
[13]	孙以民, 刘秀英.芡实内金饼治疗慢性肠炎20例[J].中国民间疗法, 1998, 6 (3):42-42.
[14]	韩建军, 宁娜.五倍子药理作用的研究进展[J].淮海医药, 2015, 33 (4):415-415.
[15]	苏万楷, 李裕, 黄家灿, 等.木槿植物资源的利用价值及开发潜力[J].四川林业科技, 2005, 26 (2):80-83.
[16]	徐春生, 李明, 李光明.中药玫瑰花的药理研究进展[J].中国医药指南, 2012, 10 (15):82-84.